Mindpeak announces its collaboration with Sagis Dx to conduct a spearheading study, assessing the efficacy of the new Mindpeak Onychomycosis AI algorithm.

Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology Funding strengthens the product development roadmap for AI-powered histopathological assessments, supporting clinical labs and biopharma companies worldwide.

Unlocking the Future of Pathology with AI: Meet our Team at ECP 2024

Mindpeak unveiled a new product to empower pathologists in detecting and grading prostate cancer.

We are looking forward to meeting you in person, at USCAP 2024, Baltimore (MD), USA. Meet our CEO Felix Faber and our experts Patrick Frey and Timm Goempel at our booth (no 863).